Print Page   |   Contact Us   |   Your Cart   |   Sign In
Search
Sign In


Breaking News
Calendar

5/31/2018 » 6/3/2018
2018 OSAP Annual Conference

News & Press: Daily Updates

Oral Smallpox Treatment Gains FDA NDA Acceptance and Priority Review

Thursday, February 15, 2018   (0 Comments)
Posted by: Samantha Auguin

The US Food and Drug Administration (FDA) has accepted SIGA Technologies, Inc's New Drug Application (NDA) for its oral formulation of the smallpox medication, tecovirimat (TPOXX).

More >>


OSAP Disclaimer | Please notify our webmaster of any problems with this website.
OSAP thanks its Super Sponsors for their support in 2018. Sponsorship does not imply endorsement by OSAP of a company's products or services.